These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10327137)

  • 21. [Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis].
    Mubiayi N; Coutty N; Detourmignies L; Le Goueff F; Decocq J; Delahousse G
    Presse Med; 2004 Aug; 33(14 Pt 1):930-3. PubMed ID: 15509046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis.
    Bessières MH; Berrebi A; Cassaing S; Fillaux J; Cambus JP; Berry A; Assouline C; Ayoubi JM; Magnaval JF
    Mem Inst Oswaldo Cruz; 2009 Mar; 104(2):389-92. PubMed ID: 19430670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy].
    Wirden M; Botterel F; Romand S; Ithier G; Bourée P
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):566-7. PubMed ID: 10598352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal toxoplasmosis and negative amniocentesis: necessity of an ultrasound follow-up.
    Gay-Andrieu F; Marty P; Pialat J; Sournies G; Drier de Laforte T; Peyron F
    Prenat Diagn; 2003 Jul; 23(7):558-60. PubMed ID: 12868082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
    McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
    Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Toxoplasma infections in early pregnancy: consequences and management].
    Wallon M; Gaucherand P; Al Kurdi M; Peyron F
    J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.
    Schmidt DR; Hogh B; Andersen O; Hansen SH; Dalhoff K; Petersen E
    Eur J Pediatr; 2006 Jan; 165(1):19-25. PubMed ID: 16133245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcome.
    Van Delden C; Hirschel B
    J Infect Dis; 1996 May; 173(5):1294-5. PubMed ID: 8627092
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants.
    Kaye A
    J Pediatr Health Care; 2011; 25(6):355-64. PubMed ID: 22018426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
    Villena I; Quereux C; Pinon JM
    Prenat Diagn; 1998 Jul; 18(7):754-6. PubMed ID: 9706662
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxoplasmosis in pregnancy and its transmission to the fetus.
    Desmonts G; Couvreur J
    Bull N Y Acad Med; 1974 Feb; 50(2):146-59. PubMed ID: 4521728
    [No Abstract]   [Full Text] [Related]  

  • 32. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
    Bessières MH; Berrebi A; Rolland M; Bloom MC; Roques C; Cassaing S; Courjault C; Séguéla JP
    Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):37-45. PubMed ID: 11134824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
    Lopes CD; Silva NM; Ferro EA; Sousa RA; Firminot ML; Bernardes ES; Roque-Barreira MC; Pena JD
    J Parasitol; 2009 Aug; 95(4):1005-10. PubMed ID: 20050006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
    Phan L; Kasza K; Jalbrzikowski J; Noble AG; Latkany P; Kuo A; Mieler W; Meyers S; Rabiah P; Boyer K; Swisher C; Mets M; Roizen N; Cezar S; Remington J; Meier P; McLeod R;
    Ophthalmology; 2008 Mar; 115(3):553-559.e8. PubMed ID: 17825418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurologic and developmental outcome in treated congenital toxoplasmosis.
    Roizen N; Swisher CN; Stein MA; Hopkins J; Boyer KM; Holfels E; Mets MB; Stein L; Patel D; Meier P
    Pediatrics; 1995 Jan; 95(1):11-20. PubMed ID: 7770286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital toxoplasmosis in twins: a case report.
    Favre R; Grangé G; Gasser B
    Fetal Diagn Ther; 1994; 9(4):264-8. PubMed ID: 7945909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis.
    Chêne G; Thiébaut R
    Mem Inst Oswaldo Cruz; 2009 Mar; 104(2):299-304. PubMed ID: 19430657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of congenital toxoplasmosis in France: current data].
    Garcia-Méric P; Franck J; Dumon H; Piarroux R
    Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Congenital toxoplasmosis: a new case of infection during pregnancy in an previously immunized and immunocompetent woman].
    Lebas F; Ducrocq S; Mucignat V; Paris L; Mégier P; Baudon JJ; Gold F
    Arch Pediatr; 2004 Aug; 11(8):926-8. PubMed ID: 15288083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital toxoplasmosis, later relapses and treatment.
    Koppe JG; Meenken C
    Acta Paediatr; 1999 Jun; 88(6):586-8. PubMed ID: 10419236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.